Mass spectrometry workflows powering the future of biologics
Analysing complex biologics is one of drug discovery’s biggest challenges.…
Analysing complex biologics is one of drug discovery’s biggest challenges. At Genentech, Rachel Shi is developing MS workflows that deliver clearer answers, faster.